Mitochondrial‐Targeting Mesoporous Polydopamine Nanoparticles for Reducing Kidney Injury Caused by Depleted Uranium
Advanced Healthcare Materials · 2025
DOI: 10.1002/adhm.202403015 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Healthcare Materials, 2025. Verfasst von Wenrun Li und 14 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Trauma and Chemical Poisoning, Institute of Combined Injury, Chongqing Engineering Research Center for Nanomedicine, College …. Hauptthemen laut MEDLINE: Indoles, Polymers, Nanoparticles, Mitochondria. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 48 Literaturangaben. Gefördert von: Science and Technology Research Program of Chongqing Municipal Education Commission, Research Project of Army Medical University.
Abstract (Originalsprache)
Depleted uranium (DU), when accidentally released from the nuclear industry, can enter the human body and cause kidney damage, as DU induces oxidative damage and apoptosis through mitochondrial pathways and inflammatory reactions. The existing nanoparticles used to treat DU injury have low bioavailability and poor targeting. In this study, mesoporous polydopamine (MPDA), poly‐(ethylene glycol) (PEG), and triphenylphosphonium (TPP) are combined to develop a novel mitochondrion‐targeting bifunctional nanoparticle, MPDA–PEG–TPP, and confirm that it can protect the kidneys from DU. This study demonstrates the high selectivity of MPDA–PEG–TPP for uranyl in uranyl chelate assays and its promising efficiency in uranyl sequestration from the kidneys, lungs, and femurs, following immediate or delayed administration of MPDA–PEG–TPP nanoparticles. In vitro assays confirm its efficiency in removing reactive oxygen species and targeting the mitochondria. In addition, in vitro and in vivo assays confirm that MPDA–PEG–TPP can reduce mitochondrial dysfunction and ameliorate kidney injury. These results suggest that MPDA–PEG–TPP is a valuable agent for ameliorating the DU‐induced kidney injury.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Trauma and Chemical Poisoning, Institute of Combined Injury, Chongqing Engineering Research Center for Nanomedicine, College of Preventive Medicine, Army Medical University, Chongqing, 400038, Ch…
Förderung
- Science and Technology Research Program of Chongqing Municipal Education Commission
- Research Project of Army Medical University
Zitieren
APA
Li, W., Shen, L., Fu, S., Li, Y., Huang, F., Li, Q., Lin, Q., Liu, H., Wang, Q., Chen, L., Tan, H., Li, J., Zhao, Y., Ran, Y., & Hao, Y. (2025). Mitochondrial‐Targeting Mesoporous Polydopamine Nanoparticles for Reducing Kidney Injury Caused by Depleted Uranium. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.202403015
Vancouver
Li W, Shen L, Fu S, Li Y, Huang F, Li Q, et al. Mitochondrial‐Targeting Mesoporous Polydopamine Nanoparticles for Reducing Kidney Injury Caused by Depleted Uranium. Advanced Healthcare Materials. 2025. doi:10.1002/adhm.202403015
BibTeX
@article{Li2025,
author = {Li, Wenrun and Shen, Li and Fu, Shiyan and Li, Yong and Huang, Feng and Li, Qi and Lin, Qinyang and Liu, Hongjia and Wang, Qiuchi and Chen, Liyi and Tan, Huanhuan and Li, Juan and Zhao, Yazhen and Ran, Yonghong and Hao, Yuhui},
title = {Mitochondrial‐Targeting Mesoporous Polydopamine Nanoparticles for Reducing Kidney Injury Caused by Depleted Uranium},
journal = {Advanced Healthcare Materials},
year = {2025},
doi = {10.1002/adhm.202403015}
}
EUVIMED